3 employees
Bioarray Therapeutics is a biotech company that is committed to transforming cancer treatment decisions and outcomes using gene profiling.
2009
$4M
from 1 investors over 1 rounds
Bioarray Therapeutics Inc. raised $4M on October 5, 2017
Investors: Quark Venture